A Multicenter, Open-label, Uncontrolled Phase II Study to Investigate Efficacy and Safety of ONO4538 in Patients With Rhabdoid Tumor
Status: Recruiting
Location: See all (5) locations...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 2
SUMMARY
Investigate the efficacy and safety of ONO-4538 for the treatment of rhabdoid Tumors
Eligibility
Participation Requirements
Sex: All
Minimum Age: 1
Healthy Volunteers: f
View:
• Gender: Not specified
• Age (at the time of consent): 1 year or older
• Patients who are refractory or intolerant to one or more regimens of chemotherapy for rhabdoid Tumors
• Patients with advanced or recurrent rhabdoid Tumors not eligible for curative resection
Locations
Other Locations
Japan
National Cancer Center Hospital
RECRUITING
Chuo-ku
Hyogo Prefectural Kobe Children's Hospital
RECRUITING
Kobe
Nagoya University Hospital
RECRUITING
Nagoya
Osaka City General Hospital
RECRUITING
Osaka
Hokkaido University Hospital
RECRUITING
Sapporo
Contact Information
Primary
North America Clinical Trial Support Desk
clinical_trial@ono-pharma.com
+18665877745(Toll-Free)
Backup
International Clinical Trial Support Desk
clinical_trial@ono-pharma.com
+17162141777(Standard)
Time Frame
Start Date: 2024-11-25
Estimated Completion Date: 2030-03-31
Participants
Target number of participants: 23
Treatments
Experimental: ONO-4538
Related Therapeutic Areas
Sponsors
Leads: Ono Pharmaceutical Co. Ltd